Aureus Asset Management, LLC does not endorse any content from third parties referenced on this site, or linked from this site.  No information displayed on this site is to be taken as investment advice.  For additional information please refer to Terms of Use for this website.

NYT: A Drug Costs $272,000 a Year. Not So Fast, Says New York State.

It’s time for courts to weigh in on the issue of drug pricing.  As an investor, we want drug companies to earn a strong return on their investment – but Read More

Economist: Most stockmarket returns come from a tiny fraction of shares

This Economist article discusses the outsized contribution of a handful of stocks to the overall market’s return. Read the full article in The Economist

CNBC: Companies have no choice now but to raise wages

Finally, after years of unrequited anticipation, we are seeing some reasonable wage growth. Here is Kari’s newest piece – click here to read the full piece on

The Economist: American tech giants are making life tough for startups

In this article The Economist details how the U.S. tech giants are making life difficult for start-ups. Read the full article in The Economist

Archive Readings and Writings